Citizens Downgrades Foghorn Therapeutics (FHTX) to Market Perform

October 1, 2026 2:55 PM

Citizens analyst Silvan Tuerkcan downgraded Foghorn Therapeutics (NASDAQ: FHTX) from Market Outperform to Market Perform.The analyst comments "Foghorn Therapeutics and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found